Indefinite Delivery Contract SPE2DX16D3915

The federal contract IDV award SPE2DX16D3915 is a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.00, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of November 23, 2023 and aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

The contract encompasses a wide variety of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains such as cardiovascular health, diabetes management, mental health treatments, pain management, infectious disease prevention, and general medical care. This IDC serves as the primary vehicle for the DLA to efficiently procure these critical pharmaceutical and medical supplies to meet the healthcare needs of military personnel, veterans, and other federal beneficiaries. Amerisourcebergen Drug Corp, as the prime contractor, leverages its extensive supply chain and distribution capabilities to fulfill delivery orders under this contract.